Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) EBT (2016 - 2026)

Avanos Medical's EBT history spans 13 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, EBT rose 100.29% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$66.2 million, a 83.59% increase, with the full-year FY2025 number at -$66.2 million, up 83.59% from a year prior.
  • EBT hit $1.2 million in Q4 2025 for Avanos Medical, up from -$1.2 million in the prior quarter.
  • Over the last five years, EBT for AVNS hit a ceiling of $14.3 million in Q4 2022 and a floor of -$420.5 million in Q4 2024.
  • Historically, EBT has averaged -$24.0 million across 5 years, with a median of $1.3 million in 2024.
  • Biggest five-year swings in EBT: crashed 4824.72% in 2024 and later skyrocketed 546.67% in 2025.
  • Tracing AVNS's EBT over 5 years: stood at -$23.1 million in 2021, then soared by 161.9% to $14.3 million in 2022, then tumbled by 37.76% to $8.9 million in 2023, then crashed by 4824.72% to -$420.5 million in 2024, then surged by 100.29% to $1.2 million in 2025.
  • Business Quant data shows EBT for AVNS at $1.2 million in Q4 2025, -$1.2 million in Q3 2025, and -$75.9 million in Q2 2025.